Jazz Pharmaceuticals (JAZZ) Short Interest Ratio & Short Volume → I’m afraid WWIII is a very real possibility (From Porter & Company) (Ad) Free JAZZ Stock Alerts $108.99 -1.50 (-1.36%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Jazz Pharmaceuticals Short Interest DataCurrent Short Volume3,600,000 sharesPrevious Short Volume3,700,000 sharesChange Vs. Previous Month-2.70%Dollar Volume Sold Short$398.70 millionShort Interest Ratio / Days to Cover5.6Last Record DateApril 30, 2024Outstanding Shares63,040,000 sharesPercentage of Shares Shorted5.71%Today's Trading Volume574,031 sharesAverage Trading Volume621,292 sharesToday's Volume Vs. Average92% Short Selling Jazz Pharmaceuticals ? Sign up to receive the latest short interest report for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatJAZZ Short Interest Over TimeJAZZ Days to Cover Over TimeJAZZ Percentage of Float Shorted Over Time Ad Stansberry ResearchA letter is coming from the "Bureau of the Fiscal Service".Is your bank next? A powerful new trend is spreading like wildfire inside the US financial system. At least 41 banks are already involved. But the Federal Reserve predicts that number will grow fast.See if your bank is involved right here. Jazz Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,600,000 shares $398.70 million -2.7%N/A5.6 $110.75 4/15/20243,700,000 shares $410.37 million +13.5%6.1%6 $110.91 3/31/20243,260,000 shares $392.57 million +17.7%5.4%5.3 $120.42 3/15/20242,770,000 shares $334.89 million +15.9%4.6%4.3 $120.90 2/29/20242,390,000 shares $284.17 million +3.0%4.0%4 $118.90 2/15/20242,320,000 shares $294.22 million +5.0%N/A4 $126.82 Get the Latest News and Ratings for JAZZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,210,000 shares $271.21 million +2.3%N/A3.4 $122.72 1/15/20242,160,000 shares $256.91 million -1.8%N/A3 $118.94 12/31/20232,200,000 shares $270.60 million -0.5%N/A3.1 $123.00 12/15/20232,210,000 shares $268.52 million -9.1%N/A3.1 $121.50 11/30/20232,430,000 shares $287.30 million -5.5%N/A3.6 $118.23 11/15/20232,570,000 shares $322.28 million -6.2%N/A4 $125.40 10/31/20232,740,000 shares $348.03 million +5.0%N/A4.5 $127.02 10/15/20232,610,000 shares $337.00 million -19.9%N/A4.7 $129.12 9/30/20233,260,000 shares $421.97 million -2.4%N/A6.9 $129.44 9/15/20233,340,000 shares $442.52 million +16.8%N/A6.8 $132.49 8/31/20232,860,000 shares $410.01 million +1.1%N/A5.4 $143.36 8/15/20232,830,000 shares $396.17 million -0.4%N/A5 $139.99 7/31/20232,840,000 shares $370.39 million -5.7%N/A5 $130.42 7/15/20233,010,000 shares $381.34 million +0.3%N/A5.3 $126.69 6/30/20233,000,000 shares $371.91 million +11.5%N/A5.4 $123.97 6/15/20232,690,000 shares $346.82 million -13.8%N/A5.1 $128.93 5/31/20233,120,000 shares $399.86 million +5.1%N/A6.3 $128.16 5/15/20232,970,000 shares $400.00 million +19.8%N/A6 $134.68 4/30/20232,480,000 shares $348.37 million +7.4%N/A5 $140.47 4/15/20232,310,000 shares $336.15 million -10.1%N/A4.8 $145.52 3/31/20232,570,000 shares $376.07 million +10.8%N/A5 $146.33 3/15/20232,320,000 shares $312.94 million -4.9%N/A4.4 $134.89 2/28/20232,440,000 shares $342.58 million -1.6%N/A4.2 $140.40 2/15/20232,480,000 shares $370.54 million -3.9%N/A4.6 $149.41 1/31/20232,580,000 shares $404.18 million -1.9%N/A4.6 $156.66 1/15/20232,630,000 shares $411.52 million -2.6%N/A4.8 $156.47 12/30/20222,700,000 shares $430.14 million +21.1%N/A5 $159.31 12/15/20222,230,000 shares $341.10 million +2.8%N/A4 $152.96 11/30/20222,170,000 shares $340.49 million -7.7%N/A4 $156.91 11/15/20222,350,000 shares $348.83 million -1.7%N/A4.5 $148.44 10/31/20222,390,000 shares $343.66 million +6.2%N/A4.7 $143.79 10/15/20222,250,000 shares $299.72 million -14.1%N/A4.3 $133.21 9/30/20222,620,000 shares $349.22 million -4.4%N/A5 $133.29 9/15/20222,740,000 shares $416.97 million -1.4%N/A5.3 $152.18[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. JAZZ Short Interest - Frequently Asked Questions What is Jazz Pharmaceuticals' current short interest? Short interest is the volume of Jazz Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,600,000 shares of JAZZ short. Learn More on Jazz Pharmaceuticals' current short interest. What is a good short interest ratio for Jazz Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JAZZ shares currently have a short interest ratio of 6.0. Learn More on Jazz Pharmaceuticals's short interest ratio. Which institutional investors are shorting Jazz Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Jazz Pharmaceuticals: Walleye Trading LLC, Jane Street Group LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Jazz Pharmaceuticals' short interest increasing or decreasing? Jazz Pharmaceuticals saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 3,600,000 shares, a drop of 2.7% from the previous total of 3,700,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Jazz Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Jazz Pharmaceuticals: Perrigo Company plc (2.54%), Mirati Therapeutics, Inc. (6.26%), Corcept Therapeutics Incorporated (22.07%), Intra-Cellular Therapies, Inc. (3.48%), Ascendis Pharma A/S (6.36%), Blueprint Medicines Co. (7.42%), Cerevel Therapeutics Holdings, Inc. (7.57%), Viking Therapeutics, Inc. (10.98%), Cytokinetics, Incorporated (13.51%), Legend Biotech Co. (7.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Jazz Pharmaceuticals stock? Short selling JAZZ is an investing strategy that aims to generate trading profit from Jazz Pharmaceuticals as its price is falling. JAZZ shares are trading down $1.50 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Jazz Pharmaceuticals? A short squeeze for Jazz Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JAZZ, which in turn drives the price of the stock up even further. How often is Jazz Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JAZZ, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PRGO Short Interest Data MRTX Short Interest Data CORT Short Interest Data ITCI Short Interest Data ASND Short Interest Data BPMC Short Interest Data CERE Short Interest Data VKTX Short Interest Data CYTK Short Interest Data LEGN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:JAZZ) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace